| Oral Cavity Squamous Cell Carcinoma studied in …STUDIED_INderived200 of 264show all (up to 200) |
|---|
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844551Phase 2 · not yet recruiting ImmunoADC Therapy for Induction Conversion in Patients With Stage IVB OSCC/OPSCC · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172258Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06258811Phase 3 · recruiting Neoadjuvant Immunochemotherapy for LAOSCC · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827872Phase 3 · not yet recruiting Neoadjuvant Sintilimab Plus Chemotherapy for cT2N0M0 Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316688Phase 1/Phase 2 · terminated A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Tongue Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734537Phase 2 · recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04191460Phase 2 · completed Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05721755Phase 3 · active not recruiting Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06055868active not recruiting People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812467Phase 2 · not yet recruiting Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090070NA · recruiting Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07484139Phase 2 · not yet recruiting H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC) · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07794813recruiting Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03258554Phase 2/Phase 3 · completed Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07058805Phase 2 · recruiting Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783581Phase 2 · not yet recruiting Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07784855NA · not yet recruiting Scheduled IV Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778368Phase 2 · not yet recruiting A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778615completed Immunohistochemical Expression of Cyclin D1 in Oral Squamous Cell Carcinoma: Relationship With Clinicodemographic and Histopathological Features · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04333537Phase 2/Phase 3 · recruiting Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532279Phase 2 · recruiting Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07766889Phase 2 · not yet recruiting Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06627270Phase 2 · recruiting Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085147Phase 1/Phase 2 · active not recruiting A Dye for the Detection of Cancer of the Tongue and Mouth · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07717307NA · recruiting Study Comparing Limited and Extensive Neck Surgery in Oral Cancer Patients With Neck Spread · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07726199NA · recruiting Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745803not yet recruiting Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06947668recruiting Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07121595Phase 2 · recruiting Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754321Phase 1 · recruiting Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858269Phase 2 · active not recruiting First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692360not yet recruiting Salivary IL-6 and Interleukin Gene Polymorphisms in Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686575recruiting Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01772706NA · completed Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667296Phase 3 · not yet recruiting APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07674706NA · not yet recruiting Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862650Phase 2 · active not recruiting Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04533750Phase 1 · active not recruiting Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07654647NA · recruiting Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction. · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494182Phase 2 · active not recruiting Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05681039Phase 2 · active not recruiting Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC). · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07606638NA · enrolling by invitation Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05791149NA · recruiting Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07579507NA · not yet recruiting Heterogeneity of Oral Carcinogenesis: From PrEneoplasia to Invasive Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03799445Phase 2 · terminated Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Posterior Tongue Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05893888Phase 2/Phase 3 · recruiting A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529769not yet recruiting Artificial Intelligence for the Diagnosis of Oral Lesions · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06097468Phase 1/Phase 2 · recruiting Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC) · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514767Phase 2 · not yet recruiting Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370276Phase 1/Phase 2 · completed Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07466810NA · not yet recruiting Resection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Tongue Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06876038Phase 2 · not yet recruiting Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06030440Phase 2/Phase 3 · recruiting De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939627Phase 2 · completed Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07457099not yet recruiting Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06868433Phase 1 · recruiting TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06336941NA · recruiting "Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON) · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07063212Phase 2 · recruiting A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06636734Phase 2 · recruiting Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01473784NA · recruiting Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05551117Phase 2 · terminated A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07335380Phase 1 · not yet recruiting Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07371611Phase 3 · recruiting Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03468218Phase 2 · active not recruiting Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05312710Phase 2 · active not recruiting Safety and Efficacy of APG-157 in Head and Neck Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346807Phase 2 · not yet recruiting Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Tongue Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07343271recruiting Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04801472NA · terminated Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM) · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934929NA · active not recruiting Contribution of Residual Tumour DNA Testing on the Surgical Bed · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827956completed Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Upper Gingival Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07306546NA · not yet recruiting Effectiveness of Hydrogen Water Intervention on Acute Oral Inflammation, Oral Microbiota, and Pain Following Free Flap Reconstruction in Patients With Oral Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04445064Phase 2 · terminated Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03381183Phase 1 · completed IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04725396NA · completed Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03021993Phase 2 · completed Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07111455recruiting Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137858Phase 2 · not yet recruiting Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07133958recruiting A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05540899Phase 1 · active not recruiting Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07079410Phase 2 · not yet recruiting Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05774483NA · recruiting Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07028918early Phase 1 · not yet recruiting A Prospective Single-Arm Study（NCLDR） · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07015333completed Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03854032Phase 2 · active not recruiting Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06009861Phase 2 · active not recruiting Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT) · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06321003recruiting SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02245100completed Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618654early Phase 1 · completed Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05144698Phase 1/Phase 2 · recruiting RAPA-201 Therapy of Solid Tumors · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03053960terminated Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861712Phase 2 · not yet recruiting Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03342911Phase 2 · completed Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05608369Phase 2 · withdrawn Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05452408Phase 1 · withdrawn Antitumor-B KAC PK Study · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02827838early Phase 1 · terminated Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861036NA · not yet recruiting Heterogeneity of Oral Squamous Cell Carcinoma Analysis by Single Cell RNA Sequencing · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03721757Phase 2 · completed CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04588038Phase 1 · terminated NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451303recruiting Detection of Oral and Throat Cancers Using OralViome Cancer Testing System · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06174428recruiting Validity of Viome's Oral/throat Cancer Test · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04883645early Phase 1 · completed Neoadjuvant Imiquimod Immunotherapy for Oral Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03459729early Phase 1 · completed Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04649476Phase 2 · completed Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06728618Phase 2 · not yet recruiting Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726512NA · not yet recruiting Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06380686recruiting Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950737NA · completed Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre Experience · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870840Phase 1 · completed Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031337completed Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06609070NA · not yet recruiting CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03028766Phase 1 · completed WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04718415Phase 2 · active not recruiting Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06599801not yet recruiting Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06425146NA · unknown Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO) · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05719779NA · unknown Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer. · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01847326Phase 1 · completed Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084845Phase 2 · withdrawn Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064479Phase 2 · completed Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03784066Phase 1/Phase 2 · unknown Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541355Phase 2 · completed Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923258Phase 2/Phase 3 · completed Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06438939NA · not yet recruiting NBI for Early Diagnosis of OPMD/OSCC · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05798793Phase 3 · recruiting Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05098119Phase 2 · recruiting Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002) · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03650699NA · completed Biofeedback Rehabilitation to Improve Speaking and Eating in Public · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02609386Phase 2 · completed IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04892875Phase 1 · withdrawn A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05069857Phase 2 · recruiting Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05125055Phase 2/Phase 3 · recruiting Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05455632completed Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and Surgery · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06130007Phase 2 · unknown A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma. · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01914900Phase 2 · completed Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05708209completed The Long Non Coding MALAT1 as a Potential Salivary Diagnostic Biomarker in Oral Squamous Cell Carcinoma Through Targeting mi RNA 124 · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016400Phase 2/Phase 3 · unknown Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05992610NA · unknown Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902455unknown Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03575598early Phase 1 · completed Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05862168Phase 2 · recruiting Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05927220unknown WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05876247unknown Articulatory Adaptation Following Oral Cancer Treatment · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05872880recruiting TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma. · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05843032NA · unknown 3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin Assessment · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Tongue Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05821179completed Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05806073NA · not yet recruiting Elective vs Therapeutic Neck Dissection in Treatment of Patients With Clinical T1/2N1M0 Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05803915Phase 2 · unknown Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04413214Phase 1 · completed Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01332279Phase 1 · withdrawn Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04614896NA · completed Use of Ultrasound for Measuring Size of Oral Tongue Cancers · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Tongue Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02582008early Phase 1 · terminated Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766150unknown Oral Microbioma and Oral Malignant Disease · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05749042Phase 2 · unknown A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05578170unknown Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05611463Phase 2 · unknown Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma Patients · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03502148Phase 1/Phase 2 · completed Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02295540NA · withdrawn Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024383NA · unknown Dissecting the Heterogeneity of Oral Cancer Pain · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01265849Phase 3 · completed Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03148665completed Saliva-based Detection of CD44 · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04831450Phase 2 · withdrawn Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03090412Phase 2 · terminated Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01884259Phase 2 · completed Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02748707Phase 2 · unknown Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01636544NA · completed Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02873819Phase 2 · completed Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05150509unknown Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass Spectroscopy · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04059861NA · completed Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical Margin · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Floor of Mouth Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03510390NA · completed Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04367909Phase 2 · unknown A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843515Phase 1 · unknown Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816984Phase 1/Phase 2 · completed PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049408completed Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04270201unknown Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01414426Phase 2 · completed Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543266unknown Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01314755NA · completed A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01249443Phase 1 · terminated Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04387682NA · unknown Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01192815Phase 2 · terminated Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02236936Phase 3 · terminated Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03440151NA · unknown Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Tongue Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01044433Phase 2 · completed Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254617Phase 1 · completed Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469429Phase 1/Phase 2 · completed Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01504932NA · completed Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors · condition mapped CURATED_BROADER · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816841NA · completed Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care · condition mapped ONTOLOGY_EXACT · 264 trials mapped (100 active) | — | — | Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03554967completed Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03418454unknown The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04137627Phase 3 · completed Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma · condition mapped ALIAS · 264 trials mapped (100 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |